2025. Trastuzumab-Conjugated Nanoparticles: Design And Synthesis Of Trastuzumab-Conjugated Nanoparticles For Targeted Delivery Of Chemotherapeutic Agents To Her2-Positive Breast Cancer Cells. Vascular and Endovascular Review. 8, 12s (Nov. 2025), 310–315.